These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8380367)

  • 1. Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS).
    Simon HU; Higgins EA; Demetriou M; Datti A; Siminovitch KA; Dennis JW
    Clin Exp Immunol; 1993 Jan; 91(1):43-9. PubMed ID: 8380367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
    Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
    Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL; Shields JG; Levinsky RJ; Callard RE
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome.
    Gulley ML; Chen CL; Raab-Traub N
    Hematol Oncol; 1993; 11(3):139-45. PubMed ID: 8112728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex formation of CD23/surface immunoglobulin and CD23/CD81/MHC class II on an EBV-transformed human B cell line and inferable role of tetraspanin.
    Kijimoto-Ochiai S; Noguchi A; Ohnishi T; Araki Y
    Microbiol Immunol; 2004; 48(5):417-26. PubMed ID: 15215629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome.
    Higgins EA; Siminovitch KA; Zhuang DL; Brockhausen I; Dennis JW
    J Biol Chem; 1991 Apr; 266(10):6280-90. PubMed ID: 2007580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD23 as a sensitive marker for Epstein-Barr virus-related disorders after liver transplantation.
    Kato H; Inamoto T; Nakamura H; Furuke K; Uemoto S; Tanaka K; Ozawa K; Hori T; Yodoi J
    Transplantation; 1993 Nov; 56(5):1109-13. PubMed ID: 8249109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
    Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
    Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
    Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.
    Garnier JL; Cooper NR; Cannon MJ
    Am J Pathol; 1993 Feb; 142(2):353-8. PubMed ID: 7679547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis.
    Ikizawa K; Yanagihara Y; Kajiwara K; Koshio T; Shida T; Yamada A
    Int Arch Allergy Immunol; 1993; 101(4):416-24. PubMed ID: 7689005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the B lymphocytes in children with infectious mononucleosis caused by Epstein-Barr Virus].
    Luo XM; Zhou FY; Zhou YL; Wang XX; Qiu LN
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):701-4. PubMed ID: 15482676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trend of the CD23+ B cells in children with infectious mononucleosis caused by Epstein-Barr virus].
    Luo XM; Zhou FY; Zhou YL; Wang XX; Qiu LN
    Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):9-12. PubMed ID: 15796797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
    Grosjean I; Lachaux A; Bella C; Aubry JP; Bonnefoy JY; Kaiserlian D
    Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of soluble CD23 in sera from patients with infectious mononucleosis.
    Hashimoto S; Takei M; Gon Y; Sawada S; Maekawa N; Yodoi J; Takada K; Horie T
    J Med Virol; 1997 Dec; 53(4):384-7. PubMed ID: 9407387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell phenotype (CD23)-dependent variation in EBV genome copy numbers within lymphoblastoid cell lines (LCL).
    Wendel-Hansen V; Tao W; Ericson M; Klein G; Rosén A
    Int J Cancer; 1992 Feb; 50(4):589-92. PubMed ID: 1311286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of lymphocytes to Epstein-Barr virus in patients with primary immunodeficiencies.
    Kondo N; Inoue R; Orii T
    J Investig Allergol Clin Immunol; 1994; 4(4):182-4. PubMed ID: 7850031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.